2024 August 27, 2024 Alex Bastian joins Memo Therapeutics AG as VP Commercial Strategy August 06, 2024 multimmune announces granting of US patent for Hsp70 based combination therapy July 08, 2024 Memo Therapeutics AG AG appoints Paul Carter as Chairperson May 07, 2024 Memo Therapeutics Increases Series C Financing To CHF 45 Million April 16, 2024 TriEye And Vertilas Partner To Demonstrate 1.3μm VCSEL-Driven SWIR Sensing Solutions March 25, 2024 Adtran And Vertilas Answer AI Demands With Industry-First Ultra-Low-Power 100G PAM4 Single-Mode VCSEL Technology February 05, 2024 Memo Therapeutics AG Strengthens Management Team
